Global Capecitabine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112280362 | Category: Pharma & Healthcare | Pages: 90 | Format: PDF | Published Date: October 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Capecitabine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Capecitabine market size is estimated to be worth US$ 1055.9 million in 2021 and is forecast to a readjusted size of USD 1027.9 million by 2028 with a CAGR of -0.4% during review period. Breast Cancer accounting for % of the Capecitabine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 500 mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Capecitabine include Roche, Teva, Mylan, Hikma, and Hengrui Medicine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Capecitabine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    500 mg
    150 mg
Market segment by Application can be divided into
    Breast Cancer
    Colorectal Cancer
    Stomach Cancer
The key market players for global Capecitabine market are listed below:
    Roche
    Teva
    Mylan
    Hikma
    Hengrui Medicine
    Cipla
    Reliance Group
    Hetero
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Capecitabine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Capecitabine, with price, sales, revenue and global market share of Capecitabine from 2019 to 2022.
Chapter 3, the Capecitabine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Capecitabine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Capecitabine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Capecitabine.
Chapter 13, 14, and 15, to describe Capecitabine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Capecitabine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Capecitabine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 500 mg
        1.2.3 150 mg
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Capecitabine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Breast Cancer
        1.3.3 Colorectal Cancer
        1.3.4 Stomach Cancer
    1.4 Global Capecitabine Market Size & Forecast
        1.4.1 Global Capecitabine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Capecitabine Sales in Volume (2017-2028)
        1.4.3 Global Capecitabine Price (2017-2028) 
    1.5 Global Capecitabine Production Capacity Analysis
        1.5.1 Global Capecitabine Total Production Capacity (2017-2028)
        1.5.2 Global Capecitabine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Capecitabine Market Drivers
        1.6.2 Capecitabine Market Restraints
        1.6.3 Capecitabine Trends Analysis
2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Capecitabine Product and Services
        2.1.4 Roche Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Teva
        2.2.1 Teva Details
        2.2.2 Teva Major Business
        2.2.3 Teva Capecitabine Product and Services
        2.2.4 Teva Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Mylan
        2.3.1 Mylan Details
        2.3.2 Mylan Major Business
        2.3.3 Mylan Capecitabine Product and Services
        2.3.4 Mylan Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Hikma
        2.4.1 Hikma Details
        2.4.2 Hikma Major Business
        2.4.3 Hikma Capecitabine Product and Services
        2.4.4 Hikma Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Hengrui Medicine
        2.5.1 Hengrui Medicine Details
        2.5.2 Hengrui Medicine Major Business
        2.5.3 Hengrui Medicine Capecitabine Product and Services
        2.5.4 Hengrui Medicine Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Cipla
        2.6.1 Cipla Details
        2.6.2 Cipla Major Business
        2.6.3 Cipla Capecitabine Product and Services
        2.6.4 Cipla Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Reliance Group
        2.7.1 Reliance Group Details
        2.7.2 Reliance Group Major Business
        2.7.3 Reliance Group Capecitabine Product and Services
        2.7.4 Reliance Group Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Hetero
        2.8.1 Hetero Details
        2.8.2 Hetero Major Business
        2.8.3 Hetero Capecitabine Product and Services
        2.8.4 Hetero Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Capecitabine Breakdown Data by Manufacturer
    3.1 Global Capecitabine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Capecitabine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Capecitabine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Capecitabine Manufacturer Market Share in 2021
        3.4.2 Top 6 Capecitabine Manufacturer Market Share in 2021
    3.5 Global Capecitabine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Capecitabine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Capecitabine Market Size by Region
        4.1.1 Global Capecitabine Sales in Volume by Region (2017-2028)
        4.1.2 Global Capecitabine Revenue by Region (2017-2028)
    4.2 North America Capecitabine Revenue (2017-2028)
    4.3 Europe Capecitabine Revenue (2017-2028)
    4.4 Asia-Pacific Capecitabine Revenue (2017-2028)
    4.5 South America Capecitabine Revenue (2017-2028)
    4.6 Middle East and Africa Capecitabine Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Capecitabine Sales in Volume by Type (2017-2028)
    5.2 Global Capecitabine Revenue by Type (2017-2028)
    5.3 Global Capecitabine Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Capecitabine Sales in Volume by Application (2017-2028)
    6.2 Global Capecitabine Revenue by Application (2017-2028)
    6.3 Global Capecitabine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Capecitabine Sales by Type (2017-2028)
    7.2 North America Capecitabine Sales by Application (2017-2028)
    7.3 North America Capecitabine Market Size by Country
        7.3.1 North America Capecitabine Sales in Volume by Country (2017-2028)
        7.3.2 North America Capecitabine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Capecitabine Sales by Type (2017-2028)
    8.2 Europe Capecitabine Sales by Application (2017-2028)
    8.3 Europe Capecitabine Market Size by Country
        8.3.1 Europe Capecitabine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Capecitabine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Capecitabine Sales by Type (2017-2028)
    9.2 Asia-Pacific Capecitabine Sales by Application (2017-2028)
    9.3 Asia-Pacific Capecitabine Market Size by Region
        9.3.1 Asia-Pacific Capecitabine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Capecitabine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Capecitabine Sales by Type (2017-2028)
    10.2 South America Capecitabine Sales by Application (2017-2028)
    10.3 South America Capecitabine Market Size by Country
        10.3.1 South America Capecitabine Sales in Volume by Country (2017-2028)
        10.3.2 South America Capecitabine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Capecitabine Sales by Type (2017-2028)
    11.2 Middle East & Africa Capecitabine Sales by Application (2017-2028)
    11.3 Middle East & Africa Capecitabine Market Size by Country
        11.3.1 Middle East & Africa Capecitabine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Capecitabine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Capecitabine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Capecitabine
    12.3 Capecitabine Production Process
    12.4 Capecitabine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Capecitabine Typical Distributors
    13.3 Capecitabine Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Capecitabine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?